Research analysts at HC Wainwright lowered their Q1 2025 earnings estimates for shares of Fulcrum Therapeutics in a report released on Wednesday, February 26th. HC Wainwright analyst A. Fein now ...

Two major players in the business email market are Google 's Gmail and Microsoft 's Outlook, as both offer a variety of ...

Fintel reports that on February 28, 2025, JP Morgan downgraded their outlook for Intellia Therapeutics (NasdaqGM:NTLA) from ...

The USDA’s Chief Economist was one of the featured speakers during the opening ceremonies of USDA’s Ag Outlook Forum Thursday ...

Outlook Therapeutics has re-submitted its Biologics License Application (BLA) to the US Food and Drug Administration (FDA) ...

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Corcept Therapeutics (CORT) one of those stocks right now?

In the United States, ONS-5010 / LYTENAVA™ (bevacizumab-vikg) is investigational.

The "Macroeconomic Outlook Report: Ireland" country profile has been added to ResearchAndMarkets.com's offering. Dublin, the capital of Ireland, contributed the most to GDP, at 51.6% in 2024, and ...